1s18

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1s18" size="450" color="white" frame="true" align="right" spinBox="true" caption="1s18, resolution 1.70&Aring;" /> '''Structure and prote...)
Line 1: Line 1:
-
[[Image:1s18.gif|left|200px]]<br />
+
[[Image:1s18.gif|left|200px]]<br /><applet load="1s18" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1s18" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1s18, resolution 1.70&Aring;" />
caption="1s18, resolution 1.70&Aring;" />
'''Structure and protein design of human apyrase'''<br />
'''Structure and protein design of human apyrase'''<br />
==Overview==
==Overview==
-
Hematophagous arthropods secrete a salivary apyrase that inhibits platelet, activation by catabolizing ADP released from damaged tissues and blood, cells. We report the X-ray crystal structures of a human enzyme of the, soluble apyrase family in its apo state and bound to a substrate analog., The structures reveal a nucleotide binding domain comprising a five-blade, beta propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function., Using a comparative structural biology approach, we were able to redesign, the human apyrase so as to enhance its ADPase activity by more than, 100-fold. The engineered enzyme is a potent inhibitor of platelet, aggregation and may serve as the basis for the development of a new class, of antithrombotic agents.
+
Hematophagous arthropods secrete a salivary apyrase that inhibits platelet activation by catabolizing ADP released from damaged tissues and blood cells. We report the X-ray crystal structures of a human enzyme of the soluble apyrase family in its apo state and bound to a substrate analog. The structures reveal a nucleotide binding domain comprising a five-blade beta propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function. Using a comparative structural biology approach, we were able to redesign the human apyrase so as to enhance its ADPase activity by more than 100-fold. The engineered enzyme is a potent inhibitor of platelet aggregation and may serve as the basis for the development of a new class of antithrombotic agents.
==About this Structure==
==About this Structure==
-
1S18 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CA, ACT and TRS as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Apyrase Apyrase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.5 3.6.1.5] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1S18 OCA].
+
1S18 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=ACT:'>ACT</scene> and <scene name='pdbligand=TRS:'>TRS</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Apyrase Apyrase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.5 3.6.1.5] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S18 OCA].
==Reference==
==Reference==
Line 19: Line 18:
[[Category: Liu, J.]]
[[Category: Liu, J.]]
[[Category: Lu, M.]]
[[Category: Lu, M.]]
-
[[Category: Smith, T.M.]]
+
[[Category: Smith, T M.]]
[[Category: ACT]]
[[Category: ACT]]
[[Category: CA]]
[[Category: CA]]
Line 28: Line 27:
[[Category: nucleotide-binding motif]]
[[Category: nucleotide-binding motif]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 19:09:07 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:56:48 2008''

Revision as of 12:56, 21 February 2008


1s18, resolution 1.70Å

Drag the structure with the mouse to rotate

Structure and protein design of human apyrase

Overview

Hematophagous arthropods secrete a salivary apyrase that inhibits platelet activation by catabolizing ADP released from damaged tissues and blood cells. We report the X-ray crystal structures of a human enzyme of the soluble apyrase family in its apo state and bound to a substrate analog. The structures reveal a nucleotide binding domain comprising a five-blade beta propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function. Using a comparative structural biology approach, we were able to redesign the human apyrase so as to enhance its ADPase activity by more than 100-fold. The engineered enzyme is a potent inhibitor of platelet aggregation and may serve as the basis for the development of a new class of antithrombotic agents.

About this Structure

1S18 is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Apyrase, with EC number 3.6.1.5 Full crystallographic information is available from OCA.

Reference

Structure and protein design of a human platelet function inhibitor., Dai J, Liu J, Deng Y, Smith TM, Lu M, Cell. 2004 Mar 5;116(5):649-59. PMID:15006348

Page seeded by OCA on Thu Feb 21 14:56:48 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools